Trxade Group (MEDS)
(Delayed Data from NSDQ)
$6.01 USD
+0.04 (0.59%)
Updated May 2, 2024 03:53 PM ET
After-Market: $6.01 0.00 (0.00%) 6:36 PM ET
NA Value
NA Growth NA Momentum NA VGMBalance Sheet
Fiscal Year End for TRxADE HEALTH, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 0 | 1 | 3 | 6 | 3 |
Receivables | 1 | 1 | 1 | 2 | 1 |
Notes Receivable | 1 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 1 | 0 |
Other Current Assets | 0 | 0 | 0 | 0 | 0 |
Total Current Assets | 3 | 2 | 4 | 9 | 4 |
Net Property & Equipment | 0 | 0 | 0 | 0 | 0 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 9 | 0 | 0 | 0 | 1 |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 13 | 4 | 6 | 10 | 6 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 7 | 0 | 0 | 0 | 0 |
Accounts Payable | 2 | 1 | 0 | 0 | 0 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 2 | 1 | 0 | 0 | 0 |
Total Current Liabilities | 12 | 2 | 1 | 1 | 1 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 12 | 3 | 2 | 1 | 1 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 34 | 20 | 20 | 20 | 13 |
Retained Earnings | -33 | -20 | -16 | -11 | -8 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 1 | 0 | 4 | 9 | 4 |
Total Liabilities & Shareholder's Equity | 13 | 4 | 6 | 10 | 6 |
Total Common Equity | 1 | 0 | 4 | 9 | 4 |
Shares Outstanding | 1.20 | 0.60 | 0.50 | 0.50 | 0.40 |
Book Value Per Share | 0.45 | 0.57 | 7.54 | 17.36 | 10.35 |
Fiscal Year End for TRxADE HEALTH, Inc falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 0 | 0 | 1 | 1 |
Receivables | NA | 1 | 1 | 1 | 1 |
Notes Receivable | NA | 1 | 1 | 0 | 0 |
Inventories | NA | 0 | 3 | 0 | 0 |
Other Current Assets | NA | 0 | 0 | 0 | 0 |
Total Current Assets | NA | 3 | 6 | 2 | 2 |
Net Property & Equipment | NA | 0 | 0 | 0 | 0 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 9 | 15 | 1 | 1 |
Deposits & Other Assets | NA | 0 | 0 | 0 | 0 |
Total Assets | NA | 13 | 22 | 4 | 4 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 7 | 5 | 0 | 0 |
Accounts Payable | NA | 2 | 1 | 1 | 1 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 0 | 0 | 0 | 0 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 2 | 2 | 3 | 2 |
Total Current Liabilities | NA | 12 | 9 | 4 | 3 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 0 | 0 | 0 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 12 | 10 | 5 | 3 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 34 | 33 | 21 | 21 |
Retained Earnings | NA | -33 | -22 | -22 | -20 |
Other Equity | NA | 0 | 0 | 0 | 0 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 1 | 12 | -1 | 1 |
Total Liabilities & Shareholder's Equity | NA | 13 | 22 | 4 | 4 |
Total Common Equity | 0 | 1 | 12 | -1 | 1 |
Shares Outstanding | 1.40 | 1.20 | 0.80 | 0.60 | 0.60 |
Book Value Per Share | 0.00 | 0.45 | 14.45 | -2.15 | 1.10 |